| Literature DB >> 28565845 |
Jianlin Liu1, Juan Dai1, Yansong Wang1, Siyu Lai1, Suwen Wang1.
Abstract
We studied the significance of new blood vessels in the pathogenesis of temporomandibular joint osteoarthritis (TMJOA). Fifteen 8-week-old female Sprague-Dawley rats were selected to establish TMJOA models of gradually induced occlusal disorders. Five rats were sacrificed at 4, 8 and 16 weeks, and histological exam was conducted along with micro-computed tomography observation on the condyle specimen. The distribution and number of new blood vessels breaking were observed through the tidemark through CD34 immunofluorescence staining. The proliferation of chondrocytes were detected through Ki67 immunohistochemical staining, and the differentiation functions of chondrocytes were observed through PTHrP and IHH immunohistochemical staining. The degradation functions of cartilage matrix were observed through matrix metalloproteinase (MMP)-9 immunohistochemical staining to detect the expression of vascular growth promotion and inhibition factors with vascular endothelial growth factor (VEGF), CTGF and CHM-1 immunohistochemical staining and screen differentially expressed genes through gene chip analysis method. It was found that the condyle tissue full thickness, fiber layer thickness and calcified cartilage layer thickness were significantly increased with time (P<0.05). Bone mineral density, trabecular thickness and Tb.Sp were also increased significantly with time, BS/BV and trabecular number were decreased significantly with time (P<0.05). The new blood vessels reached the deep layer of calcified cartilage until the tide line was broken and non-calcified cartilage was invaded. The number of vessels were increased significantly with time (P<0.05). Ki67, PTHrP and IHH-positive rates were increased significantly (P<0.05). MMP-9, VEGF, CTGF and CHM-1 were increased significantly (P<0.05). VEGF, CTGF and CHM-1 mRNA were upregulated differentially with the expressed genes. In conclusion, the new blood vessels may be important in the pathogenesis of TMJOA.Entities:
Keywords: CD34; CHM-1; CTGF; IHH; Ki67; PTHrP; gene chip; matrix metalloproteinase; new blood vessels; temporomandibular joint osteoarthritis; vascular endothelial growth factor
Year: 2017 PMID: 28565845 PMCID: PMC5443314 DOI: 10.3892/etm.2017.4234
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Figure 1.Test flow chart.
Figure 2.TMJOA model. TMJOA, temporomandibular joint osteoarthritis.
Figure 3.Condyle tissues full thickness, fiber layer thickness and calcified cartilage layer thickness increased with time.
Histological condyle tissue observation (µm).
| Items | 4 weeks | 8 weeks | 16 weeks | F-value | P-value |
|---|---|---|---|---|---|
| Full-layer thickness | 166.4±23.5 | 183.2±26.8 | 221.7±30.3 | 6.569 | 0.012 |
| Fiber layer thickness | 45.5±7.2 | 51.2±7.6 | 56.8±7.7 | 6.238 | 0.015 |
| Calcified cartilage layer thickness | 71.4±8.3 | 78.2±8.5 | 84.4±8.6 | 6.425 | 0.013 |
Micro-CT scanning of condyle tissue.
| Items | 4 weeks | 8 weeks | 16 weeks | F-value | P-value |
|---|---|---|---|---|---|
| BMD (mg/cm3) | 412.3±56.5 | 526.4±62.3 | 729.2±75.8 | 12.532 | <0.001 |
| BS/BV(mm) | 42.5±4.7 | 33.6±4.2 | 25.2±3.3 | 10.527 | <0.001 |
| Tb.N (mm) | 11.5±2.3 | 8.6±1.7 | 6.2±1.4 | 8.624 | <0.001 |
| Tb.Th (mm) | 0.04±0.01 | 0.06±0.02 | 0.10±0.03 | 9.466 | <0.001 |
| Tb.Sp (mm) | 0.05±0.01 | 0.06±0.01 | 0.07±0.01 | 7.452 | <0.001 |
Micro-CT, micro-computed tomography; BS/BV, bone surface/bone volume; Tb.N, trabecular number; Tb.Th, trabecular thickness.
Figure 4.Condyle CD34 immunofluorescence staining (the arrow shows the tide line and the asterisk shows the vessel labeled with CD34).
Comparison of the number of new blood vessels (vessel/HP).
| Items | 4 weeks | 8 weeks | 16 weeks | F-value | P-value |
|---|---|---|---|---|---|
| Number of blood vessels ending in the calcified cartilage layer | 15.3±4.2 | 17.2±4.6 | 19.6±4.8 | 7.629 | <0.001 |
| Number of blood vessels ending in the non-calcified cartilage layer | 1.5±0.3 | 2.2±0.5 | 3.7±0.9 | 9.432 | <0.001 |
Figure 5.Condylar cartilage Ki67.
Figure 6.PTHrP and IHH immunohistochemical staining (x200) (A, PTHrP and B, IHH). Immunohistochemical staining (the arrow shows expression of Ki67 in the proliferation layer, fibrous layer and hypertrophic layer).
Figure 7.(A) MMP-9, (B) VEGF, (C) CTGF and (D) CHM-1 immunohistochemical staining. MMP, matrix metalloproteinase; VEGF, vascular endothelial growth factor.
Positive expression rates of MMP-9, VEGF, CTGF and CHM-1 (%).
| Items | 4 weeks | 8 weeks | 16 weeks | F-value | P-value |
|---|---|---|---|---|---|
| MMP-9 | 5.3±1.1 | 6.7±1.2 | 8.2±1.3 | 7.451 | <0.001 |
| VEGF | 3.2±0.5 | 3.6±0.7 | 4.4±0.8 | 6.957 | <0.001 |
| CTGF | 4.3±0.6 | 4.5±0.7 | 4.9±0.8 | 5.865 | <0.001 |
| CHM-1 | 4.5±1.2 | 6.6±1.4 | 8.3±1.6 | 7.702 | <0.001 |
MMP, matrix metalloproteinase; VEGF, vascular endothelial growth factor.
Figure 8.The screening of differentially expressed genes by gene chip analysis method.